Friday, December 03, 2021

NEWS

Immunology impact on Covid-19 highlighted in Cuba

Immunology impact on Covid-19 highlighted in Cuba

Havana, Apr 30 (Prensa Latina) Immunology has been pivotal in Cuba during this year for fighting the Covid-19 pandemic, according to the Ministry of Public Health (MINSAP).
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

Dr. Consuelo Macías, MINSAP´s head of the National Immunology Group, explained that the immunology greatest impact has been related to coronavirus diagnosis and treatment, which includes development of technologies for detection, presence of antibodies in Covid-19 patient and titers after immunization, as parts of clinical trials.

She also added that anti-inflammatory biotechnological products have been introduced in the treatment of patients with moderate, severe and critical coronavirus symptoms, in addition to the use of interferon as antivirals since the onset of the disease.

Specialists are currently involved in developing the five Covid-19 vaccine candidates for immunizing Cuban people.

Immunology is also linked to the viral neutralization management from specific antibodies transfer, through convalescent plasma transfusion and the use of advanced treatments. Among these treatments are the application of Regenerative Medicine (RM) through the immunoregulatory action of stem cells in convalescent patient with complications such as lung injuries.

Dr. Macías ensured that immunology has a multidisciplinary scope and as a basic medical, diagnostic and clinical specialty, it is a cornerstone for Cuba´s National Health System.

ef/pll/jha/rbp

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.